Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C27H30O14 |
| Molecular Weight | 578.5187 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 10 / 10 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@@H]1O[C@@H](OC2=CC3=C(C(O)=C2)C(=O)C(O[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)=C(O3)C5=CC=C(O)C=C5)[C@H](O)[C@H](O)[C@H]1O
InChI
InChIKey=PUPKKEQDLNREIM-QNSQPKOQSA-N
InChI=1S/C27H30O14/c1-9-17(30)20(33)22(35)26(37-9)39-13-7-14(29)16-15(8-13)40-24(11-3-5-12(28)6-4-11)25(19(16)32)41-27-23(36)21(34)18(31)10(2)38-27/h3-10,17-18,20-23,26-31,33-36H,1-2H3/t9-,10-,17-,18-,20+,21+,22+,23+,26-,27-/m0/s1
| Molecular Formula | C27H30O14 |
| Molecular Weight | 578.5187 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 10 / 10 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Lespedin (Kaempferitrin) is extracted in significantly high quantities from the leaves of Cinnamomum osmophloeum (C.O) and Bauhinia forficata, and are used as an antidiabetic herbal remedy in China and Brazil. Commercial product using dry Cinnamomum osmophloeum leaves has been sold locally in Taiwan. Oral administration of kaempferitrin reduced blood sugar in diabetic rats. Lespedin possessed significant antiosteoporotic activity. Combined with its limited estrogen-like side effect, Lespedin can be regarded as an idealistic antiosteoporotic candidate for human osteoporosis diseases. Kaempferitrin was found to have an acute lowering effect on blood glucose in diabetic rats and to stimulate the glucose uptake percentile, as efficiently as insulin in muscle from normal rats.
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL3737 Sources: https://www.ncbi.nlm.nih.gov/pubmed/25532842 |
|||
Target ID: CHEMBL1250410 Sources: https://www.ncbi.nlm.nih.gov/pubmed/19146827 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
|||
| Preventing | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/28551543
Curator's Comment: Lespedin (Kaempferitrin) at 5, 10, and 20 mg/kg orally induced an antidepressant-like effect in two behavior models in mice https://www.ncbi.nlm.nih.gov/pubmed/25532842
Lespedin (Kaempferitrin) and ETX were administered via intracerebroventricular (i.c.v, 4th ventricle, 1ug/μL) and tested in the presence of PTZ in rats.
Route of Administration:
Other
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/23588095
Lespedin (Kaempferitrin) at 25uM, the highest concentration tested, increased the proliferation of murine macrophages (23%) and splenocytes (17%), and human PBMC (24%) in the absence of lipopolysaccharides (LPS), compared to untreated cells.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 21:21:14 GMT 2025
by
admin
on
Mon Mar 31 21:21:14 GMT 2025
|
| Record UNII |
VPV01U3R59
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
100000077108
Created by
admin on Mon Mar 31 21:21:14 GMT 2025 , Edited by admin on Mon Mar 31 21:21:14 GMT 2025
|
PRIMARY | |||
|
68883
Created by
admin on Mon Mar 31 21:21:14 GMT 2025 , Edited by admin on Mon Mar 31 21:21:14 GMT 2025
|
PRIMARY | |||
|
m6592
Created by
admin on Mon Mar 31 21:21:14 GMT 2025 , Edited by admin on Mon Mar 31 21:21:14 GMT 2025
|
PRIMARY | Merck Index | ||
|
DTXSID90197458
Created by
admin on Mon Mar 31 21:21:14 GMT 2025 , Edited by admin on Mon Mar 31 21:21:14 GMT 2025
|
PRIMARY | |||
|
482-38-2
Created by
admin on Mon Mar 31 21:21:14 GMT 2025 , Edited by admin on Mon Mar 31 21:21:14 GMT 2025
|
PRIMARY | |||
|
5486199
Created by
admin on Mon Mar 31 21:21:14 GMT 2025 , Edited by admin on Mon Mar 31 21:21:14 GMT 2025
|
PRIMARY | |||
|
VPV01U3R59
Created by
admin on Mon Mar 31 21:21:14 GMT 2025 , Edited by admin on Mon Mar 31 21:21:14 GMT 2025
|
PRIMARY | |||
|
Kaempferitrin
Created by
admin on Mon Mar 31 21:21:14 GMT 2025 , Edited by admin on Mon Mar 31 21:21:14 GMT 2025
|
PRIMARY | |||
|
SUB14349MIG
Created by
admin on Mon Mar 31 21:21:14 GMT 2025 , Edited by admin on Mon Mar 31 21:21:14 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> CONSTITUENT ALWAYS PRESENT |